Výsledky vyhledávání - "David Jiménez Ruiz De La Torre"

Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic

Autor: Alberto Mussetti, Maria Queralt Salas Gay, Maria Condom, Maite Antonio, Cristian Ochoa, Iulia Ivan, David Jiménez Ruiz De La Torre, Gabriela Isabel Sanz-Linares, Belen Ansoleaga, Rocio Parody, Ali Bazarbachi, Anna Sureda Balari

Publikováno v: Blood

Introduction An increased risk of mortality has been documented in transplanted patients affected by Coronavirus Disease 2019 (COVID19) with an estimated mortality rate between 20-40%. Multiple efforts are ongoing to control COVID19 pandemic, and cli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ca0887ccf42d87ecbc55474be2c474d
http://europepmc.org/articles/PMC8330239

Zobrazit plný text záznamu

Use of Telehealth for Domiciliary Follow-up After Hematopoietic Cell Transplantation During the COVID-19 Pandemic: Prospective Pilot Study

Autor: Cristian Ochoa, Maite Antonio, Rocío Parody, Maria Queralt Salas, Beatriz Patiño-Gutierrez, Gabriela Sanz Linares, Maria Condom, David Jiménez Ruiz De La Torre, Laura Jimenez-Prat, Iulia Ivan, Ana Sureda-Balari, Alberto Mussetti, Belen Ansoleaga

Publikováno v: JMIR Formative Research
JMIR Formative Research, Vol 5, Iss 3, p e26121 (2021)

Background Patients who have recently received a hematopoietic cell transplant (HCT) are at higher risk of acute complications in the first weeks after discharge, especially during the COVID-19 pandemic. Objective The aim of this study was to test th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fb4682453f5dbdf2dc916b057469fe7
https://pubmed.ncbi.nlm.nih.gov/33600351

Zobrazit plný text záznamu

Subcutaneous Bortezomib, Thalidomide and Dexamethasone As Induction Therapy Prior to Autologous Peripheral Blood Stem Cell Transplantation in Young Patients Diagnosed of Multiple Myeloma. a Retrospective Analysis from Two Centers

Autor: Gladys Ibarra, Laura Abril, David Jiménez Ruiz De La Torre, Anna Sureda, Josep-Maria Ribera, Maite Encuentra, Albert Oriol

Publikováno v: Blood
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname

INTRODUCTION The combination of intravenous bortezomib, thalidomide and dexamethasone (VTD) is a well described induction treatment for young patients with multiple myeloma (MM) that are candidates to be consolidated with an autologous stem cell tran

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1994c7b120fdf90a9361cb6177015afb
https://fundanet.igtp.cat/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2713

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání